Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0124)

Montreal, Quebec H2X 3E4

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Colorectal Cancer

Studies at this site

• Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer (mCRC) Participants (MK-3475-651/KEYNOTE-651) — Completed